Hormone Sensitive Metastatic Prostate Cancer
1 clinical trials · Condition
◉ Watch Hormone Sensitive Metastatic Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer (NCT05461261) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2022-07-01 |
Track Hormone Sensitive Metastatic Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.